Elsevier

Fertility and Sterility

Volume 98, Issue 3, September 2012, Pages 692-701.e5
Fertility and Sterility

Original article
Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study

https://doi.org/10.1016/j.fertnstert.2012.04.022Get rights and content
Under a Creative Commons license
open access

Objective

To generate and validate symptom-based models to predict endometriosis among symptomatic women prior to undergoing their first laparoscopy.

Design

Prospective, observational, two-phase study, in which women completed a 25-item questionnaire prior to surgery.

Setting

Nineteen hospitals in 13 countries.

Patient(s)

Symptomatic women (n = 1,396) scheduled for laparoscopy without a previous surgical diagnosis of endometriosis.

Intervention(s)

None.

Main Outcome Measure(s)

Sensitivity and specificity of endometriosis diagnosis predicted by symptoms and patient characteristics from optimal models developed using multiple logistic regression analyses in one data set (phase I), and independently validated in a second data set (phase II) by receiver operating characteristic (ROC) curve analysis.

Result(s)

Three hundred sixty (46.7%) women in phase I and 364 (58.2%) in phase II were diagnosed with endometriosis at laparoscopy. Menstrual dyschezia (pain on opening bowels) and a history of benign ovarian cysts most strongly predicted both any and stage III and IV endometriosis in both phases. Prediction of any-stage endometriosis, although improved by ultrasound scan evidence of cyst/nodules, was relatively poor (area under the curve [AUC] = 68.3). Stage III and IV disease was predicted with good accuracy (AUC = 84.9, sensitivity of 82.3% and specificity 75.8% at an optimal cut-off of 0.24).

Conclusion(s)

Our symptom-based models predict any-stage endometriosis relatively poorly and stage III and IV disease with good accuracy. Predictive tools based on such models could help to prioritize women for surgical investigation in clinical practice and thus contribute to reducing time to diagnosis. We invite other researchers to validate the key models in additional populations.

Key Words

Endometriosis
predictive model
logistic regression

Cited by (0)

K.E.N. has nothing to disclose. L.H. has nothing to disclose. S.H.K. has nothing to disclose. C.J. has nothing to disclose. K.T.Z. has nothing to disclose.

Supported in part by a grant to the World Endometriosis Research Foundation (WERF) from TAP Pharmaceuticals (now Abbott Endocrine) (L.H., K.T.Z., and S.H.K.). K.T.Z. received payment for translation of the study questionnaire into Dutch. L.H. and S.H.K. have been consultants for Abbott.